w 7 has been researched along with adenosine diphosphate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belushkina, NN; Khropov, IuV; Kulagin, SV; Severina, IS; Shirkov, IuIu; Tyshchuk, IA | 1 |
| Azuma, H; Hidaka, H; Nishikawa, M; Yamakado, T | 1 |
| Blackburn, KJ; Higgins, AJ | 1 |
| Akkerman, JW; Burgers, JA | 1 |
| Hatae, N; Ichikawa, A; Negishi, M; Sugimoto, Y; Yamaoka, K | 1 |
| Andrews, RK; Arthur, JF; Berndt, MC; Gachet, C; Leon, C; Mu, FT; Shen, Y | 1 |
| Furuichi, M; Hisasue, M; Kitao, S; Kobayashi, K; Neo, S; Tatsuki, Y; Tsuchiya, R; Yamada, T | 1 |
7 other study(ies) available for w 7 and adenosine diphosphate
| Article | Year |
|---|---|
[Effect of N-(6-aminohexyl)-5-chloronaphthalene-1-sulfamide (W-7) and its analogs on the activity of soluble guanylate cyclase and on human platelet aggregation].
Topics: Adenosine Diphosphate; Guanylate Cyclase; Humans; Molecular Structure; Platelet Aggregation Inhibitors; Solubility; Sulfonamides | 1990 |
Pharmacological properties of platelet strips.
Topics: Adenosine Diphosphate; Alprostadil; Angiotensin II; Aorta; Blood Platelets; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Papaverine; Platelet Aggregation; Prostaglandins E; Serotonin; Sulfonamides; Time Factors | 1983 |
Prevention of reperfusion damage in working rat hearts by calcium antagonists and calmodulin antagonists.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Calcium; Calcium Channel Blockers; Calmodulin; Cardiac Output; Coronary Circulation; Coronary Disease; Diltiazem; L-Lactate Dehydrogenase; Male; Myocardium; Nifedipine; Perfusion; Phosphocreatine; Rats; Rats, Inbred Strains; Sulfonamides; Verapamil | 1984 |
Regulation of the receptor for platelet-activating factor on human platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Alkaloids; Antimycin A; Blood Platelets; Calmodulin; Cyclic AMP; Deoxyglucose; Energy Metabolism; Humans; Phosphoproteins; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase C; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sphingosine; Staurosporine; Sulfonamides | 1993 |
Augmentation of receptor-mediated adenylyl cyclase activity by Gi-coupled prostaglandin receptor subtype EP3 in a Gbetagamma subunit-independent manner.
Topics: Adenosine Diphosphate; Adenylate Cyclase Toxin; Adenylyl Cyclases; Alprostadil; Animals; Calcium; Calmodulin; Cell Membrane; Chelating Agents; Cloning, Molecular; COS Cells; Cyclic AMP; Dinoprostone; DNA, Complementary; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, Gi-Go; Pertussis Toxin; Prostaglandins; Prostaglandins E, Synthetic; Protein Structure, Tertiary; Rats; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Sulfonamides; Virulence Factors, Bordetella | 2002 |
Calmodulin interacts with the platelet ADP receptor P2Y1.
Topics: Adenosine Diphosphate; Amino Acid Sequence; Binding Sites; Blood Platelets; Calcium; Calcium Signaling; Calmodulin; Humans; Platelet Activation; Platelet Aggregation; Protein Binding; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Sulfonamides | 2006 |
Characterization of canine platelet activation induced by platelet activating factor (PAF).
Topics: Adenosine Diphosphate; Animals; Calcium; Collagen; Dogs; Platelet Activating Factor; Platelet Activation; Sulfonamides | 2008 |